20516 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Esters of saccharides
PHENYLEPHRINE TANNATE, PYRILAMINE TANNATE AND DEXTROMETHORPHAN TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS
#302PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH MONO- AND DISACCHARIDE-BASED COMPOUNDS
#303Drugs for chronic pains
#304Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
#305Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#306Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#307Inhibition of cathepsin K activity and the treatment and prevention of disease
#308Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
#309GALLOTANNINS AND ELLIGITANNINS AS REGULATORS OF CYTOKINE RELEASE
#310COMPOSITIONS FOR VAGINAL TREATMENT
#311Treatments for wound healing
#312Identification and Use of Non-Peptide Analogs of RNAIII-Inhibiting Peptide for the Treatment of Staphylococcal Infections
#313Elastin stabilization of connective tissue
#314Lipase Inhibitors
#315Stabilized pentosan polysulfate (PPS) formulations and methods of analyzing them
#316Method for regulating the appearance of skin containing combination of skin care actives
#317Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
#318USE OF OLIGOSACCHARIDE FOR PREVENTING BLOOD CLOTTING IN EXTRACORPOREAL BLOOD CIRCUITS
#319PHENYLEPHRINE TANNATE AND PYRILAMINE TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS
#320Drugs for chronic pains
#321Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
#322Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
#323Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
#324Sulfatides for treatment of autoimmune disorders
#325Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
#326Polymeric micellar complexes and drug delivery vehicles thereof
#327Method for treating intermittent claudication comprising the administration of propionyl L-carnitine and a concomitant physical training
#328Compositions and methods for the prevention and treatment of circulatory conditions
#329Angiogenic agents from plant extracts, gallic acid, and derivatives
#330Peroxide removal from drug delivery vehicle
#331Photoprotector and/or photoimmunoprotector compositions of the skin and their uses
#332Tannate compositions, methods of making and methods of use
#333Proteasome inhibitors and uses thereof
#334Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant
#335Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders
#336Methods and composition for the treatment of cystic fibrosis and related illnesses
#337Medicinal compositions and therapeutic methods for treating arthritis and other painful conditions
#338Compositions of flavones and long chain fatty acid derivatives isolated from plants and methods related thereto for the control of prostate disorders
#339Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes
#340Elastin stabilization of connective tissue
#341Combination therapy for effecting weight loss and treating obesity
#342Treatment of migraine
#343PXR agonists for cardiovascular disease
#344Pharmaceutical compositions of drugs and neutralized acidic polymers
#345Method of treating hit patients with argatroban
#346Novel chemical entities and methods for their use in treatment of metabolic disorders
#347Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
#348Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss
#349Liposome formulations of boronic acid compounds
#350Liposome formulations of boronic acid compounds
#351Combination therapy for the treatment of dyslipidemia
#352Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
#353Fluid wound dressing comprising partially cured polyurethane
#354Methods for inhibition of NKT cells
#355Methods and compositions for therapeutic treatment
#356Methods and compositions for treating pain
#357Antimicrobial molecule
#358TONIC TO MAINTAIN INTESTINAL FLORA
#359Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant
#360Dengue virus infection inhibitor
#361Treatment of dyskinesia
#362Methods and compositions for treating diabetes mellitis
#363Topical anhydrous delivery system for antioxidants
#364Tyrosinase activity controlling agent, process for producing the same and external preparation containing the same
#365Method for treating obesity
#366Pharmaceutical compositions of drugs and neutralized acidic polymers
#367Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
#368Sucrose ester compounds useful as fungicides
#369Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
#370Methods and compositions for treatment of neurological disorder
#371Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract
#372Treatment of papillomavirus infections
#373Use of sugar esters in cosmetic and/or pharmaceutical preparations
#374Method for treating obesity
#375Idraparinux (SanOrg34006) for treatment of venous events in patients with deep venous thrombosis
#376Compositions for vaginal treatment
#377Method of making a lanolin free absorption base
#378Induction of antigen specific immunologic tolerance
#379Micelles
#380Antifungal properties of various forms of sophorolipids
#381Use of an anti-endotoxin drug in the prevention and treatment of disease
#382Method for treating obesity
#383Activated protein c formulations
#384Method for treating obesity
#385Saccharide compositions and method of use
#386Prevention and treatment of endotoxemia and related complications associated with surgery
#387Treatments for neurogenetic disorders, impulse control disorders, and wound healing
#388Weight reduction and maintenance method for animals
#389Antimicrobial composition
#390Diphenhydramine tannate liquid and semi-solid compositions and methods of use
#391Diphenhydramine tannate solid dose compositions and methods of use
#392Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
#393Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
#394Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
#395Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase
#396Compositions and methods for treating pain
#397Synthesis of high molecular weight iron-saccharidic complexes
#398Method for treating alcoholic hepatitis
#399Alternative agent with vitamin D-like activity and an improving agent for intestinal function
#400Compositions and methods directed towards sore muscles and joints
#401Highly pure fondaparinux sodium composition, process for preparing said composition and pharmaceutical compositions containing it as active principle
#402Process for preparing tannate liquid and semi-solid dosage forms
#403Effective method for regulating the appearance of skin
#404Intestinal mineral absorption capacity improver
#405Compositions and methods for borocarbohydrate complexes
#406Multi-component formulations for the treatment of cognitive decline including Alzheimer's disease
#407Composition having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction